Silver and fullerene nanoparticles' effect on interleukin-2-dependent proliferation of CD4 (+) T cells

Toxicology in Vitro

Volumn 28, Issue 8, 2014, Pages 1474-1481

  Côté Maurais, Guillaume ^a   Bernier, Jacques ^a  

^a INRS INSTITUT ARMAND FRAPPIER   (Canada)

Author keywords

Fullerene; IL 2; Nanoparticle; Silver; T lymphocyte; Toxicity

Indexed keywords

EID: 84908674107     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2014.08.005     Document Type: Article

References (52)

1. Arora S., Jain J., Rajwade J.M., Paknikar K.M. Interactions of silver nanoparticles with primary mouse fibroblasts and liver cells. Toxicol. Appl. Pharmacol. 2009, 236:310-318.
2. Aschberger K., Johnston H.J., Stone V., Aitken R.J., Tran C.L., Hankin S.M., Peters S.A., Christensen F.M. Review of fullerene toxicity and exposure-appraisal of a human health risk assessment, based on open literature. Regul. Toxicol. Pharmacol. 2010, 58:455-473.
3. Asharani P.V., Low Kah Mun G., Hande M.P., Valiyaveettil S. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano 2009, 3:279-290.
4. Bhol K.C., Schechter P.J. Topical nanocrystalline silver cream suppresses inflammatory cytokines and induces apoptosis of inflammatory cells in a murine model of allergic contact dermatitis. Br. J. Dermatol. 2005, 152:1235-1242.
5. Bihari P., Vippola M., Schultes S., Praetner M., Khandoga A.G., Reichel C.A., Coester C., Tuomi T., Rehberg M., Krombach F. Optimized dispersion of nanoparticles for biological in vitro and in vivo studies. Part. Fibre Toxicol. 2008, 5:14.
6. Chen W., Zhang Q., Kaplan B.L., Baker G.L., Kaminski N.E. Induced T cell cytokine production is enhanced by engineered nanoparticles. Nanotoxicology 2013.
7. D'Elia M., Patenaude J., Dupras C., Bernier J. Burn injury induces the expression of cystine/glutamate transporter (xc-) in mouse T cells. Immunol. Lett. 2009, 125:137-144.
8. D'Elia M., Patenaude J., Dupras C., Bernier J. T cells from burn-injured mice demonstrate a loss of sensitivity to glucocorticoids. Am. J. Physiol. Endocrinol. Metab. 2010, 299:E299-E307.
9. Dugan L.L., Lovett E.G., Quick K.L., Lotharius J., Lin T.T., O'Malley K.L. Fullerene-based antioxidants and neurodegenerative disorders. Parkinsonism Relat. Disord. 2001, 7:243-246.
10. Eom H.J., Choi J. P38 MAPK activation, DNA damage, cell cycle arrest and apoptosis as mechanisms of toxicity of silver nanoparticles in Jurkat T cells. Environ. Sci. Technol. 2010, 44:8337-8342.
11. Foldbjerg R., Olesen P., Hougaard M., Dang D.A., Hoffmann H.J., Autrup H. PVP-coated silver nanoparticles and silver ions induce reactive oxygen species, apoptosis and necrosis in THP-1 monocytes. Toxicol. Lett. 2009, 190:156-162.
12. Gaffen S.L. Signaling domains of the interleukin 2 receptor. Cytokine 2001, 14:63-77.
13. Gaffen S.L., Liu K.D. Overview of interleukin-2 function, production and clinical applications. Cytokine 2004, 28:109-123.
14. Gharbi N., Pressac M., Hadchouel M., Szwarc H., Wilson S.R., Moussa F. [60]Fullerene is a powerful antioxidant in vivo with no acute or subacute toxicity. Nano Lett. 2005, 5:2578-2585.
15. Greulich C., Diendorf J., Gessmann J., Simon T., Habijan T., Eggeler G., Schildhauer T.A., Epple M., Koller M. Cell type-specific responses of peripheral blood mononuclear cells to silver nanoparticles. Acta Biomater. 2011, 7:3505-3514.
16. Guo D., Zhu L., Huang Z., Zhou H., Ge Y., Ma W., Wu J., Zhang X., Zhou X., Zhang Y., Zhao Y., Gu N. Anti-leukemia activity of PVP-coated silver nanoparticles via generation of reactive oxygen species and release of silver ions. Biomaterials 2013.
17. Hatakeyama M., Mori H., Doi T., Taniguchi T. A restricted cytoplasmic region of IL-2 receptor beta chain is essential for growth signal transduction but not for ligand binding and internalization. Cell 1989, 59:837-845.
18. Hemler M.E., Brenner M.B., McLean J.M., Strominger J.L. Antigenic stimulation regulates the level of expression of interleukin 2 receptor on human T cells. Proc. Natl. Acad. Sci. USA 1984, 81:2172-2175.
19. Horie M., Nishio K., Kato H., Shinohara N., Nakamura A., Fujita K., Kinugasa S., Endoh S., Yamamoto K., Yamamoto O., Niki E., Yoshida Y., Iwahashi H. In vitro evaluation of cellular responses induced by stable fullerene C60 medium dispersion. J. Biochem. 2010, 148:289-298.
20. Hrebinyk S.M., Hryniuk I.I., Pryluts'ka S.V., Matyshevs'ka O.P. Generation of active oxygen forms in rat thymocytes under action of hydrogen peroxide and fullerene C60. Ukr. Biokhim. Zh. 2012, 84:48-52.
21. Kim S., Ryu D.Y. Silver nanoparticle-induced oxidative stress, genotoxicity and apoptosis in cultured cells and animal tissues. J. Appl. Toxicol. 2013, 33:78-89.
22. Krug H.F., Wick P. Nanotoxicology: an interdisciplinary challenge. Angew. Chem. Int. Ed. Engl. 2011, 50:1260-1278.
23. Liao W., Lin J.X., Wang L., Li P., Leonard W.J. Modulation of cytokine receptors by IL-2 broadly regulates differentiation into helper T cell lineages. Nat. Immunol. 2011, 12:551-559.
24. Liu Y., Jiao F., Qiu Y., Li W., Qu Y., Tian C., Li Y., Bai R., Lao F., Zhao Y., Chai Z., Chen C. Immunostimulatory properties and enhanced TNF-alpha mediated cellular immunity for tumor therapy by C60(OH)20 nanoparticles. Nanotechnology 2009, 20:415102.
25. Malek T.R. The biology of interleukin-2. Annu. Rev. Immunol. 2008, 26:453-479.
26. Malek T.R., Bayer A.L. Tolerance, not immunity, crucially depends on IL-2. Nat. Rev. Immunol. 2004, 4:665-674.
27. Markovic Z., Trajkovic V. Biomedical potential of the reactive oxygen species generation and quenching by fullerenes (C60). Biomaterials 2008, 29:3561-3573.
28. Monti D., Moretti L., Salvioli S., Straface E., Malorni W., Pellicciari R., Schettini G., Bisaglia M., Pincelli C., Fumelli C., Bonafe M., Franceschi C. C60 carboxyfullerene exerts a protective activity against oxidative stress-induced apoptosis in human peripheral blood mononuclear cells. Biochem. Biophys. Res. Commun. 2000, 277:711-717.
29. Mor F., Cohen I.R. IL-2 rescues antigen-specific T cells from radiation or dexamethasone-induced apoptosis. Correlation with induction of Bcl-2. J. Immunol. 1996, 156:515-522.
30. Moriggl R., Topham D.J., Teglund S., Sexl V., McKay C., Wang D., Hoffmeyer A., van Deursen J., Sangster M.Y., Bunting K.D., Grosveld G.C., Ihle J.N. Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells. Immunity 1999, 10:249-259.
31. Morimoto Y., Hirohashi M., Ogami A., Oyabu T., Myojo T., Nishi K., Kadoya C., Todoroki M., Yamamoto M., Murakami M., Shimada M., Wang W.N., Yamamoto K., Fujita K., Endoh S., Uchida K., Shinohara N., Nakanishi J., Tanaka I. Inflammogenic effect of well-characterized fullerenes in inhalation and intratracheal instillation studies. Part. Fibre Toxicol. 2010, 7:4.
32. Murdock R.C., Braydich-Stolle L., Schrand A.M., Schlager J.J., Hussain S.M. Characterization of nanomaterial dispersion in solution prior to in vitro exposure using dynamic light scattering technique. Toxicol. Sci. 2008, 101:239-253.
33. Oberdorster G. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology. J. Intern. Med. 2010, 267:89-105.
34. Oberdorster G., Maynard A., Donaldson K., Castranova V., Fitzpatrick J., Ausman K., Carter J., Karn B., Kreyling W., Lai D., Olin S., Monteiro-Riviere N., Warheit D., Yang H. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part. Fibre Toxicol. 2005, 2:8. Group I.R.F.R.S.I.N.T.S.W.
35. Park E.J., Kim H., Kim Y., Yi J., Choi K., Park K. Carbon fullerenes (C60s) can induce inflammatory responses in the lung of mice. Toxicol. Appl. Pharmacol. 2010, 244:226-233.
36. Prasad R.Y., Mcgee J.K., Killius M.G., Ackerman D., Blackman C.F., Demarini D.M., Simmons S.O. Investigating oxidative stress and inflammatory responses elicited by silver nanoparticles using high-throughput reporter genes in HepG2 cells: effect of size, surface coating, and intracellular uptake. Toxicol In Vitro 2013.
37. Rebollo A., Pitton C., Garcia A., Gomez J., Silva A. A role for the intermediate affinity IL-2R in the protection against glucocorticoid-induced apoptosis. Immunology 1995, 84:388-395.
38. Roursgaard M., Poulsen S.S., Kepley C.L., Hammer M., Nielsen G.D., Larsen S.T. Polyhydroxylated C60 fullerene (fullerenol) attenuates neutrophilic lung inflammation in mice. Basic Clin. Pharmacol. Toxicol. 2008, 103:386-388.
39. Shin S.H., Ye M.K., Kim H.S., Kang H.S. The effects of nano-silver on the proliferation and cytokine expression by peripheral blood mononuclear cells. Int. Immunopharmacol. 2007, 7:1813-1818.
40. Stensberg M.C., Wei Q., McLamore E.S., Porterfield D.M., Wei A., Sepulveda M.S. Toxicological studies on silver nanoparticles: challenges and opportunities in assessment, monitoring and imaging. Nanomedicine (Lond) 2011, 6:879-898.
41. Suzuki H., Toyooka T., Ibuki Y. Simple and easy method to evaluate uptake potential of nanoparticles in mammalian cells using a flow cytometric light scatter analysis. Environ. Sci. Technol. 2007, 41:3018-3024.
42. Tian J., Wong K.K., Ho C.M., Lok C.N., Yu W.Y., Che C.M., Chiu J.F., Tam P.K. Topical delivery of silver nanoparticles promotes wound healing. ChemMedChem 2007, 2:129-136.
43. Torres M., Forman H.J. Redox signaling and the MAP kinase pathways. Biofactors 2003, 17:287-296.
44. Tulinska J., Kazimirova A., Kuricova M., Barancokova M., Liskova A., Neubauerova E., Drlickova M., Ciampor F., Vavra I., Bilanicova D., Pojana G., Staruchova M., Horvathova M., Jahnova E., Volkovova K., Bartusova M., Cagalinec M., Dusinska M. Immunotoxicity and genotoxicity testing of PLGA-PEO nanoparticles in human blood cell model. Nanotoxicology 2013.
45. Walsh P.T., Buckler J.L., Zhang J., Gelman A.E., Dalton N.M., Taylor D.K., Bensinger S.J., Hancock W.W., Turka L.A. PTEN inhibits IL-2 receptor-mediated expansion of CD4+ CD25+ Tregs. J. Clin. Invest. 2006, 116:2521-2531.
46. Wei L., Tang J., Zhang Z., Chen Y., Zhou G., Xi T. Investigation of the cytotoxicity mechanism of silver nanoparticles in vitro. Biomed. Mater. 2010, 5:044103.
47. Wong K.K., Cheung S.O., Huang L., Niu J., Tao C., Ho C.M., Che C.M., Tam P.K. Further evidence of the anti-inflammatory effects of silver nanoparticles. ChemMedChem 2009, 4:1129-1135.
48. Xia J., Zhang S., Zhang Y., Ma M., Xu K., Tang M., Gu N. The relationship between internalization of magnetic nanoparticles and changes of cellular optical scatter signal. J. Nanosci. Nanotechnol. 2008, 8:6310-6315.
49. Xiao L., Takada H., Gan X., Miwa N. The water-soluble fullerene derivative "Radical Sponge" exerts cytoprotective action against UVA irradiation but not visible-light-catalyzed cytotoxicity in human skin keratinocytes. Bioorg. Med. Chem. Lett. 2006, 16:1590-1595.
50. Yamashita K., Sakai M., Takemoto N., Tsukimoto M., Uchida K., Yajima H., Oshio S., Takeda K., Kojima S. Attenuation of delayed-type hypersensitivity by fullerene treatment. Toxicology 2009, 261:19-24.
51. Yin J.J., Lao F., Fu P.P., Wamer W.G., Zhao Y., Wang P.C., Qiu Y., Sun B., Xing G., Dong J., Liang X.J., Chen C. The scavenging of reactive oxygen species and the potential for cell protection by functionalized fullerene materials. Biomaterials 2009, 30:611-621.
52. Zucker R.M., Massaro E.J., Sanders K.M., Degn L.L., Boyes W.K. Detection of TiO2 nanoparticles in cells by flow cytometry. Cytometry A 2010, 77:677-685.